Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus

Magdalena Kwiatek1, Sylwia Parasion, Lidia Mizak

  • 1Military Institute of Hygiene and Epidemiology, Lubelska Str. 2, 24-100, Puławy, Poland. magda.kwiatek09@gmail.com

Archives of Virology
|November 3, 2011
PubMed

Insights

A novel bacteriophage, MSA6, was characterized for potential use against Methicillin-resistant Staphylococcus aureus (MRSA). This virulent phage shows promise as an alternative therapeutic agent for MRSA infections.

Area of Science:

  • Microbiology
  • Virology
  • Antibiotic Resistance

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of antibiotic-resistant infections.
  • Novel therapeutic strategies are crucial to combat the growing threat of MRSA.
  • Bacteriophage therapy presents a potential alternative to conventional antibiotics.

Purpose of the Study:

  • To characterize a newly isolated virulent bacteriophage, designated MSA6.
  • To evaluate the potential of bacteriophage MSA6 as a therapeutic agent against MRSA.

Main Methods:

  • Isolation and characterization of bacteriophage MSA6 from a bovine mastitis case.
  • Electron microscopy for morphological analysis.
  • Pulsed-field gel electrophoresis for genome size estimation.
  • Adsorption, latent period, and burst size assays.
  • Testing infectivity against a spectrum of staphylococcal strains.

Main Results:

  • Phage MSA6 morphology is consistent with the Myoviridae family (isometric head, contractile tail).
  • Estimated genome size of phage MSA6 is approximately 143 kb.
  • MSA6 demonstrated rapid adsorption (>82% in 5 min), a short latent period (15 min), and a burst size of 23 PFU/cell.
  • The phage effectively infected a broad range of staphylococcal strains from human and bovine sources.

Conclusions:

  • Bacteriophage MSA6 is a virulent phage with characteristics similar to Myoviridae family members.
  • MSA6 shows potential for therapeutic applications against MRSA infections.
  • Further investigation into MSA6 efficacy in bacteriophage therapy is warranted.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
Bacteriophages of the Human Virome01:23

Bacteriophages of the Human Virome

Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...